维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="YASEN M"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence:A prospective,multicenter study显示文摘	Tanaka S Mogushi K Yasen M	2011	Hepatology2011，54，4：	1
	2	The selective Aurora-B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma显示文摘	Aihara A Tanaka S J Yasen M		0，，01：	1
	3	The histologic effects of the Uyghur medicine Xipayi KuiJiean on ulcerative colitis in rats 显示文摘	Halmurat U Kurexi Y Yasen M	2011	JAust Tradit-Med Soc2011，17，4：	1
	4	The selective Aurora B kinase inhibitor AZDl152 as a novel treatment for hepatocellular carcinoma 显示文摘	Aihara A Tanaka S Yasen M et at	2010	J Hepatol2010，52，1：	1
	5	Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue显示文摘	Yasen M Mizushima H Mogushi K	2009	Cancer Sci2009，100，3：	1
	6	The up-regulation of Y-box bind- ing proteins (DNA binding protein A and Y-box binding protein-1 ) as prognostic markers of hepatoeellular carcinoma 显示文摘	Yasen M Kajino K Kano S	2005	Clin Cancer Res2005，11，20：	1
	7	Upregulation of protein tyro- sine phosphatase type IVA member 3 ( PTP4A3/PRL-3 ) is associated with tumor differentiation and a poor prognosis in human bepatocellu- lar carcinoma显示文摘	Mayinuer A Yasen M Mognshi K	2013	Ann Surg Oncol2013，20，1：	1
	8	The selective Au- rora - B kinase inhibitor AZD1152 as a novel treatment for hepa- tocellular carcinoma 显示文摘	AIHARA A TANAKA S YASEN M	2010	Journal of Hepatology2010，52，：	1
	9	The selective Aurora B kinase inhibitor AZDl152 as a novel treatment for hepato- cellular carcinoma显示文摘	Aihara A Tanaka S Yasen M	2010	Journal of Hepatology2010，52，：	1
	10	The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma显示文摘	Aihara A Tanaka S Yasen M		0，，01：	1
	11	Expression of Auro- ra B and ahemative variant forms in hepatocellular carcinoma and adjacent tissue显示文摘	Yasen M Mizushima H Mogushi K	2009	Cancer Sci2009，100，3：	1
	12	Upregulation of pro- tein tyrosine phosphatase type IVA member 3(PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma 显示文摘	Mayinuer A Yasen M Mogushi K	2013	Ann Surg Oncol2013，20，1：	1
	13	Surgical contribution to recurrence-free survival in patients with macrovascular invasion- negative hepatocellular carcinoma 显示文摘	Tanaka S Mogushi K Yasen M	2009	J Am Coll Surg2009，208，3：	1
	14	Upregulation of protein tyrosine phosphatase type IVA member 3(PTP4A3/PRL-3)is associated with tumor differentiation and a poor prognosis in human hepatocellular caicinoma显示文摘	MAYINUER A YASEN M MOGUSHI K	2013	Ann Surg Oncol2013，20，：	1
	15	The up-regulation of Y-box binding proteins ( DNA binding protein A and Y-box binding protein-i) as prognostic markers of hepatocellular carcinoma显示文摘	Yasen M Kajino K Kano S	2005	Clin Cancer Res2005，11，20：	1
	16	Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma显示文摘	Mayinuer A Yasen M Mogushi K etal	2013	Ann Surg Oncol2013，20，1：	1
	17	Expression of aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue显示文摘	Yasen M Mizushima H Mogushi K	2009	Cancer Sci2009，100，3：	1
	18	Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas显示文摘	Tanaka S Mogushi K Yasen M	2010	Surgery2010，147，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费